Rezultaty - Vikram Sinha

  • Rezultaty 1 - 10 Rezultaty od 10
Redukuj rezultaty
  1. 1
    Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK

    Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK od Christian Wagner, Ping Zhao, Y. Pan, Vicky Hsu, Joseph A. Grillo, S-M Huang, Vikram Sinha

    Wydane 2015
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives

    The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives od Yuzhuo Pan, Vicky Hsu, Manuela Grimstein, Lei Zhang, Vikram Arya, Vikram Sinha, Joseph A. Grillo, Ping Zhao

    Wydane 2016
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  3. 3
    Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism

    Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism od Mary Courtney Moore, Marta S. Smith, Vikram Sinha, John M. Beals, M. Dodson Michael, Scott J. Jacober, Alan D. Cherrington

    Wydane 2013
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  4. 4
    A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes

    A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes od Richard M. Bergenstal, Julio Rosenstock, Richard F. Arakaki, Melvin Prince, Yongming Qu, Vikram Sinha, Daniel C. Howey, Scott J. Jacober

    Wydane 2012
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  5. 5
    Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes

    Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes od Julio Rosenstock, Richard M. Bergenstal, Thomas Blevins, Linda Morrow, Melvin Prince, Yongming Qu, Vikram Sinha, Daniel C. Howey, Scott J. Jacober

    Wydane 2012
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  6. 6
    Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling

    Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling od Nitin Mehrotra, Atul Bhattaram, Justin Earp, J Florian, Kevin Krudys, Jung Eun Lee, J. Y. Lee, Jiaming Liu, Yeruk Mulugeta, Jiajie Yu, Ping Zhao, Vikram Sinha

    Wydane 2016
    Dokumenty pełnotekstowe
    Revisão
    Dodaj do listy ulubionych książek
    Zapisane w:
  7. 7
    Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance

    Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance od David C. Turner, Anna Kondic, Keaven M. Anderson, Andrew Robinson, Edward B. Garon, Jonathan W. Riess, Lokesh Jain, Kapil Mayawala, Jiannan Kang, Scot Ebbinghaus, Vikram Sinha, Dinesh P. de Alwis, Julie A. Stone

    Wydane 2018
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  8. 8
    Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis

    Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis od Daniela J. Conrado, Timothy Nicholas, Kuenhi Tsai, Sreeraj Macha, Vikram Sinha, Julie A. Stone, Brian Corrigan, Massimo Bani, Pierandrea Muglia, Ian A. Watson, Volker D. Kern, Елена Шевелева, Kenneth Marek, Diane Stephenson, Klaus Romero

    Wydane 2017
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  9. 9
    Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders

    Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders od Andrew E. Mulberg, Christina Bucci‐Rechtweg, Joseph Giuliano, David Jacoby, Franklin K. Johnson, Qing Liu, Deborah Marsden, Scott McGoohan, Robert M. Nelson, Nita Patel, Klaus Romero, Vikram Sinha, Sheela Sitaraman, John Spaltro, Vivian Kessler

    Wydane 2019
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  10. 10
    Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

    Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects od Robert R. Henry, Sunder Mudaliar, Theodore P. Ciaraldi, Debra Armstrong, P. Burke, Jeremy Pettus, Parag Garhyan, Siak Leng Choi, Scott J. Jacober, Mary Pat Knadler, Eric Chen Quin Lam, Melvin Prince, Namrata Bose, Niels Pörksen, Vikram Sinha, Helle Linnebjerg

    Wydane 2014
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: